ESH Video

4th Translational Research Conference: Chronic Lymphocytic Leukaemia

4th Translational Research Conference: Chronic Lymphocytic Leukaemia
March 05 - March 07, 2026 - Stockholm, Sweden - #ESHCLL2026
Chairs : Jennifer Brown, Paolo Ghia, Michael Hallek

Information

4th Translational Research Conference 
Chronic Lymphocytic Leukaemia

March 05-07, 2026

Stockholm, Sweden
#ESHCLL2026

Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek

ABOUT THE CONFERENCE:

The ESH 4th Translational Research Conference: Chronic Lymphocytic Leukaemia proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. The presentation of new data is encouraged, as well as spirited debates on how to use this knowledge to the future of CLL therapy.

This translational research conference fosters scientific exchange between laboratory scientists and clinicians working on translational CLL research worldwide. It provides opportunities for education and international networking to basic and clinical scientists, including those still in-training.

A first-class selection of international speakers will guarantee the highest quality of science and a summary of the most recent developments in the biology and therapy of CLL.

This educational conference has been approved for 17 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH)!


SCIENTIFIC TOPICS:

– Spectrum of CLL – one disease or more
– Richter transformation
– Drivers of disease progression – from genetics, epigenetics, and proteomics (complexity of the evolution)
– The microenvironment of CLL
– Time limited therapies: which combination? which duration? which markers to stop therapy?
– BTK inhibition or degradation?
– The new challenge: resistance to one or two inhibitor classes? – Double refractory CLL
– Future therapies, new compounds
– Directions and strategies to use the best agents in the optimal way: sequencing, combinations, costs of therapy, availability

 

LEARNING OBJECTIVES:

Upon completion of this CME activity, participants include:
– Understand recent advances in elucidating the pathogenesis of CLL
– Describe recent data on therapeutic regimens for CLL
– Understand emerging data on mechanisms of resistance to targeted agents in CLL
– Understand the debate about how best to optimize CLL therapy in the future

 

The meeting will be of interest to:

– Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
– Junior scientists and clinicians (MD, PhD)
– PhD candidates and clinical residents still in-training

 

THE PROGRAMME WILL INCLUDE:
– Plenary Sessions
– Debates
– Panel Discussions
– Poster Walks
– Meet the Expert Sessions
– Brief Oral Communications
– Ample time for in-depth discussion

For more information on this conference, please contact Changyi Jiang

This conference is a Face to Face meeting. No virtual attendance is scheduled.

 

 

 

Programme

Click HERE to read the final scientific programme!

 

Abstract submission

CALL FOR ABSTRACTS IS CLOSED.
The deadline was on January 4th, 2026 23:59 (CET)

 

Guidelines for your abstract submission:

1. Your abstract should be structured (e.g. Objectives, Methods, Results, Conclusions)

2. Maximum number of words: 500

3. Your abstract will be submitted to the peer review procedure.

We accept “encore” abstract.
Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

.

 

Symposia

Accommodation

 

****

Warning!
We have detected scam activity of a company trying to sell accommodation services to the speakers of our conferences. Apparently, they have been collecting information on the speakers from the lists that are made public on our websites.
Please make sure you book your accommodation either via the link(s) provided by ESH on this page, or directly with the hotel or renown booking services platform.

Venue

Hotel Clarion
Ringvägen 98
10460 Stockholm, Sweden

 

Corporate partners

With the support of*:
 
AstraZeneca Major Conference Sponsor ****
 
 

 

 

Lilly logo

Level 1 Conference Partners ****

 
 

*ESH conference programmes are developed in strict scientific independence with no input from corporate sponsors.

Scholarships

Workshop

Educational Grants

Registration

The registration fee for the ESH 4th Translational Research Conference on Chronic Lymphocytic Leukaemia is:
– 600€ for fully trained
– 300€ for in-training *
– 300€ Allied Health Professionals
– 600€ for Corporate
*A proof will be requested to confirm your status.

 

ESH is pleased to offer BHS, BSH, DGHO, HSH, OeGHO, PTHiT, SEHH, SFH (French), SFH (Swedish) & SPH Members a 20% discount on the conference registration fees.

 

This fee includes:
– Your seat in the Conference Room
– The conference materials,
– Welcome cocktail, luncheons, refreshments throughout the conference.
Your seat in the conference will be definitively reserved upon receipt of your fee.

 

Cancellation policy of registration fee :
In case of cancellation, up until two months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified between 60 to 15 days prior to the beginning of the meeting, 50% of the registration fee will be reimbursed (less bank charges). Cancellations notified 15 days before the meeting will not be reimbursed. For credit card payments please register on-line first. Please note that ESH can accept VISA and MASTERCARD/EUROCARD.